Renin Angiotensin system-modifying therapies are associated with improved pulmonary health
Abstract Background Pulmonary diseases are often complicated and have diverse etiologies. One common factor is the lack of therapeutics available for these diseases. The goal of this study was to investigate the impact of Renin-Angiotensin System (RAS)-modifying medications on incidence and time to...
Main Authors: | Maira Soto, Soo I. Bang, Jeff McCombs, Kathleen E. Rodgers |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-06-01
|
Series: | Clinical Diabetes and Endocrinology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40842-017-0044-1 |
Similar Items
-
Targeting the Protective Arm of the Renin-Angiotensin System to Reduce Systemic Lupus Erythematosus Related Pathologies in MRL-lpr Mice
by: Maira Soto, et al.
Published: (2020-07-01) -
Impact of renin-angiotensin system inhibitors continuation versus discontinuation on outcome after major surgery: protocol of a multicenter randomized, controlled trial (STOP-or-NOT trial)
by: Matthieu Legrand, et al.
Published: (2019-03-01) -
Renin-Angiotensin-Aldosterone axis inhibition improves outcome of diabetic patients with chronic hypertension and COVID-19: An Iranian perspective
by: Zahedin Kheyri, et al.
Published: (2022-01-01) -
Comparative Effectiveness of Renin-Angiotensin System Antagonists in Maintenance Dialysis Patients
by: Theresa I. Shireman, et al.
Published: (2016-11-01) -
Therapeutic Implications of Renin–Angiotensin System Modulators in Alzheimer’s Dementia
by: Daniela-Carmen Ababei, et al.
Published: (2023-09-01)